155 related articles for article (PubMed ID: 31448054)
1.
Yokomizo R; Yanaihara N; Yamaguchi N; Saito M; Kawabata A; Takahashi K; Takenaka M; Yamada K; Shapiro JS; Okamoto A
Oncotarget; 2019 Aug; 10(47):4880-4893. PubMed ID: 31448054
[TBL] [Abstract][Full Text] [Related]
2. Soluble IL6R represents a miR-34a target: potential implications for the recently identified IL-6R/STAT3/miR-34a feed-back loop.
Li H; Rokavec M; Hermeking H
Oncotarget; 2015 Jun; 6(16):14026-32. PubMed ID: 26091352
[TBL] [Abstract][Full Text] [Related]
3. IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis.
Rokavec M; Öner MG; Li H; Jackstadt R; Jiang L; Lodygin D; Kaller M; Horst D; Ziegler PK; Schwitalla S; Slotta-Huspenina J; Bader FG; Greten FR; Hermeking H
J Clin Invest; 2014 Apr; 124(4):1853-67. PubMed ID: 24642471
[TBL] [Abstract][Full Text] [Related]
4. IL-6R/STAT3/miR-204 feedback loop contributes to cisplatin resistance of epithelial ovarian cancer cells.
Zhu X; Shen H; Yin X; Long L; Chen X; Feng F; Liu Y; Zhao P; Xu Y; Li M; Xu W; Li Y
Oncotarget; 2017 Jun; 8(24):39154-39166. PubMed ID: 28388577
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA Gene Expression Signature Driven by miR-9 Overexpression in Ovarian Clear Cell Carcinoma.
Yanaihara N; Noguchi Y; Saito M; Takenaka M; Takakura S; Yamada K; Okamoto A
PLoS One; 2016; 11(9):e0162584. PubMed ID: 27612152
[TBL] [Abstract][Full Text] [Related]
6. Liujunzi decoction exerts potent antitumor activity in oesophageal squamous cell carcinoma by inhibiting miR-34a/STAT3/IL-6R feedback loop, and modifies antitumor immunity.
Han Y; Fan X; Fan L; Wu Y; Zhou Z; Wang G; Guo L; Gao W; Chen Y; Gao Q
Phytomedicine; 2023 Mar; 111():154672. PubMed ID: 36701994
[TBL] [Abstract][Full Text] [Related]
7. IL-6 induces tumor suppressor protein tyrosine phosphatase receptor type D by inhibiting miR-34a to prevent IL-6 signaling overactivation.
Zhang F; Wang B; Qin T; Wang L; Zhang Q; Lu Y; Song B; Yu X; Li L
Mol Cell Biochem; 2020 Oct; 473(1-2):1-13. PubMed ID: 32602014
[TBL] [Abstract][Full Text] [Related]
8. Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer.
Schmid G; Notaro S; Reimer D; Abdel-Azim S; Duggan-Peer M; Holly J; Fiegl H; Rössler J; Wiedemair A; Concin N; Altevogt P; Marth C; Zeimet AG
BMC Cancer; 2016 Feb; 16():102. PubMed ID: 26879132
[TBL] [Abstract][Full Text] [Related]
9. Antitumor effects of interleukin-6 (IL-6)/interleukin-6 receptor (IL-6R) signaling pathway inhibition in clear cell carcinoma of the ovary.
Yanaihara N; Hirata Y; Yamaguchi N; Noguchi Y; Saito M; Nagata C; Takakura S; Yamada K; Okamoto A
Mol Carcinog; 2016 May; 55(5):832-41. PubMed ID: 25856562
[TBL] [Abstract][Full Text] [Related]
10. Possible Role of IL-6R/STAT3/MiRNA-34a Feedback Loop in Osteosarcoma.
Amer MF; Mohamed A; Ismail A; Bayoumi LA; Shibel PEE; Elnaggar GN
Asian Pac J Cancer Prev; 2023 Sep; 24(9):3269-3274. PubMed ID: 37774081
[TBL] [Abstract][Full Text] [Related]
11.
Saini U; Suarez AA; Naidu S; Wallbillich JJ; Bixel K; Wanner RA; Bice J; Kladney RD; Lester J; Karlan BY; Goodfellow PJ; Cohn DE; Selvendiran K
Cancer Res; 2018 Apr; 78(7):1739-1750. PubMed ID: 29339537
[TBL] [Abstract][Full Text] [Related]
12. Dysregulated miR-124 and miR-200 expression contribute to cholangiocyte proliferation in the cholestatic liver by targeting IL-6/STAT3 signalling.
Xiao Y; Wang J; Yan W; Zhou Y; Chen Y; Zhou K; Wen J; Wang Y; Cai W
J Hepatol; 2015 Apr; 62(4):889-96. PubMed ID: 25450715
[TBL] [Abstract][Full Text] [Related]
13. miR-451 acts as a suppressor of angiogenesis in hepatocellular carcinoma by targeting the IL-6R-STAT3 pathway.
Liu X; Zhang A; Xiang J; Lv Y; Zhang X
Oncol Rep; 2016 Sep; 36(3):1385-92. PubMed ID: 27461244
[TBL] [Abstract][Full Text] [Related]
14. Malignant ascites enhances migratory and invasive properties of ovarian cancer cells with membrane bound IL-6R in vitro.
Kim S; Gwak H; Kim HS; Kim B; Dhanasekaran DN; Song YS
Oncotarget; 2016 Dec; 7(50):83148-83159. PubMed ID: 27825119
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-34a affects chondrocyte apoptosis and proliferation by targeting the SIRT1/p53 signaling pathway during the pathogenesis of osteoarthritis.
Yan S; Wang M; Zhao J; Zhang H; Zhou C; Jin L; Zhang Y; Qiu X; Ma B; Fan Q
Int J Mol Med; 2016 Jul; 38(1):201-9. PubMed ID: 27247228
[TBL] [Abstract][Full Text] [Related]
16. [Expression and significance of microRNAs in the p53 pathway in ovarian cancer cells and serous ovarian cancer tissues].
Zhang Q; He XJ; Ma LP; Li N; Yang J; Cheng YX; Cui H
Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):885-90. PubMed ID: 22340095
[TBL] [Abstract][Full Text] [Related]
17. Profile of differentially expressed miRNAs in high-grade serous carcinoma and clear cell ovarian carcinoma, and the expression of miR-510 in ovarian carcinoma.
Zhang X; Guo G; Wang G; Zhao J; Wang B; Yu X; Ding Y
Mol Med Rep; 2015 Dec; 12(6):8021-31. PubMed ID: 26497752
[TBL] [Abstract][Full Text] [Related]
18. Long Non-Coding RNA MAGI2-AS3 is a New Player with a Tumor Suppressive Role in High Grade Serous Ovarian Carcinoma.
Gokulnath P; de Cristofaro T; Manipur I; Di Palma T; Soriano AA; Guarracino MR; Zannini M
Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31842477
[TBL] [Abstract][Full Text] [Related]
19. miR-451a suppression of IL-6R can inhibit proliferation and increase apoptosis through the JAK2/STAT3 pathway in multiple myeloma.
Zhong L; Xu Z; Jin X; He Y; Zhang J; Jiang T; Chen J
Oncol Lett; 2020 Dec; 20(6):339. PubMed ID: 33123250
[TBL] [Abstract][Full Text] [Related]
20. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
[No Abstract] [Full Text] [Related]
[Next] [New Search]
